263690 — Drgem Income Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedMicro CapContrarian

Annual income statement for Drgem, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	106,604	85,750	110,165	112,917	104,006
Cost of Revenue
Gross Profit	38,787	27,171	36,711	29,617	30,413
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Total Operating Expenses	83,614	73,362	93,206	102,845	95,155
Operating Profit	22,990	12,389	16,959	10,071	8,850
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	22,133	14,348	17,234	10,516	11,374
Provision for Income Taxes
Net Income After Taxes	19,988	12,553	14,393	9,191	10,147
Net Income Before Extraordinary Items
Net Income	19,988	12,553	14,393	9,191	10,147
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	19,988	12,553	14,393	9,191	10,147
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	1,786	1,123	1,308	834	910
Dividends per Share